Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cell carcinoma (RCC). Despite the existing extensive research, the molecular and pathogenic mechanisms of ccRCC are elusive. We aimed to identify the immune-related lncRNA signature and molecular subtypes associated with ccRCC. By integrating 4 microarray datasets from Gene Expression Omnibus database, we identified 49 immune-related genes. The corresponding immune-related lncRNAs were further identified in the TCGA dataset. 12-lncRNAs prognostic and independent signature was identified through survival analysis and survival difference between risk groups was further identified based on the risk score. Besides, we identified 3 molecular subtypes and survival analysis result showed that cluster 2 has a better survival outcome. Further, ssGSEA enrichment analysis for the immune-associated gene sets revealed that cluster 1 corresponded to a high immune infiltration level. While cluster 2 and cluster 3 corresponded to low and medium immune infiltration level, respectively. In addition, we validated the 12-lncRNA prognostic signature and molecular subtypes in an external validation dataset from the ICGC database. In summary, we identified a 12-lncRNA prognostic signature which may provide new insights into the molecular mechanisms of ccRCC and the molecular subtypes provided a theoretical basis for personalized treatment by clinicians. Renal cell carcinoma (RCC) accounts for over 90% of all kidney cancer cases among human adults 1. Clear cell renal cell carcinoma (ccRCC) is the most common RCC histological subtype which responsible for 70-80% of RCC cases 2. Recent studies estimate that 102,000 patients succumb to ccRCC and 202,000 new cases are diagnosed annually throughout the globe 3. Besides, ccRCC has no clear symptoms in its early stages therefore can only be diagnosed in advanced stages 4. Despite interventions through chemotherapy and radiotherapy, ccRCC is prone to distant metastasis. These metastases occur in lung, bone, liver, distant lymph nodes, and renal vein 5. A few effective biomarkers, particularly in both early and advanced stages of ccRCC, have been identified. The recent version of the human genome annotation transcribes approximately 16,000 long non-coding RNAs (lncRNAs) responsible for 26.7% of the total genes (https ://www.genco degen es.org/human /) 6. lncRNAs are non-coding RNAs composed of about 200 nucleotides in length. They include the antisense lncRNAs, intronic transcripts, large intergenic noncoding RNAs (lincRNAs), promoter-associated lncRNAs, and UTR associated lncRNAs 7. Previous studies have revealed that lncRNA plays an important role in regulating gene expression, epigenetics, cell differentiation, and ontogeny 8,9. Additionally, studies have shown that massive aberrantly expressed